Skip to main content



Detailed Schedule

Detailed Schedule

  • Monday, June 15, 2026
  • 6:00 AM - 8:00 AM CT
    Advancing Acromegaly Care: Diving Deeper Into Diagnosis, Guideline Application, and Emerging Therapies
  • 7:00 AM - 8:00 AM CT
    GELC Breakfast Meeting (by invitation only)
  • 7:00 AM - 6:00 PM CT
    Speaker Ready Room
  • 7:00 AM - 6:15 PM CT
    Registration
  • 7:00 AM - 7:30 PM CT
    Quiet Room
  • 7:00 AM - 8:00 PM CT
    Coat & Luggage Check
  • 7:30 AM - 6:30 PM CT
    KiddieCorp Room
  • 8:00 AM - 9:15 AM CT
    Molecular Mechanisms in Hormone Signaling: From Bench to Bedside
  • 8:30 AM - 5:00 PM CT
    Members' Lounge
  • 9:00 AM - 2:00 PM CT
    ENDOExpo
  • 9:00 AM - 2:00 PM CT
    PSTR150 - Neuroendocrinology and Pituitary: Antidiuretic Hormone Disorders III
    Neuroendocrinology and Pituitary
  • 9:00 AM - 2:00 PM CT
    PSTR151 - Neuroendocrinology and Pituitary: Cushing Disease III
    Neuroendocrinology and Pituitary
  • 9:00 AM - 2:00 PM CT
    PSTR152 - Neuroendocrinology and Pituitary: Disorders of Growth Hormone III
    Neuroendocrinology and Pituitary
  • 9:00 AM - 2:00 PM CT
    PSTR153 - Neuroendocrinology and Pituitary: Genetics and Development (including gene regulation) II
    Neuroendocrinology and Pituitary
  • 9:00 AM - 2:00 PM CT
    PSTR154 - Neuroendocrinology and Pituitary: GHRH, GH, and IGF Biology and Prolactin Biology and Signaling III
    Neuroendocrinology and Pituitary
  • 9:00 AM - 2:00 PM CT
    PSTR155 - Neuroendocrinology and Pituitary: GnRH and Gonadotroph Biology and Signaling
    Neuroendocrinology and Pituitary
  • 9:00 AM - 2:00 PM CT
    PSTR156 - Neuroendocrinology and Pituitary: Hypopituitarism III
    Neuroendocrinology and Pituitary
  • 9:00 AM - 2:00 PM CT
    PSTR157 - Neuroendocrinology and Pituitary: Cushing Disease III
  • 9:00 AM - 2:00 PM CT
    PSTR157 - Neuroendocrinology and Pituitary: Neuroendorine Tumors III
    Neuroendocrinology and Pituitary
  • 9:00 AM - 2:00 PM CT
    PSTR158 - Neuroendocrinology and Pituitary: Non-functioning Pituitary Tumors and other Sellar/Parasellar Tumors III
    Neuroendocrinology and Pituitary
  • 9:00 AM - 2:00 PM CT
    PSTR159 - Neuroendocrinology and Pituitary: Other Functioning Pituitary Tumors II
    Neuroendocrinology and Pituitary
  • 9:00 AM - 2:00 PM CT
    PSTR160 - Neuroendocrinology and Pituitary: Prolactinoma III
    Neuroendocrinology and Pituitary
  • 9:00 AM - 2:00 PM CT
    PSTR161 - Reproductive Endocrinology: Female Reproductive Health and Biology III
    Reproductive Endocrinology
  • 9:00 AM - 2:00 PM CT
    PSTR162 - Reproductive Endocrinology: Genetics and Development (including gene regulation) II
    Reproductive Endocrinology
  • 9:00 AM - 2:00 PM CT
    PSTR163 - Reproductive Endocrinology: Male Reproductive Health, Biology including Reproductive Tract III
    Reproductive Endocrinology
  • 9:00 AM - 2:00 PM CT
    PSTR164 - Reproductive Endocrinology: Menopause II
    Reproductive Endocrinology
  • 9:00 AM - 2:00 PM CT
    PSTR165 - Reproductive Endocrinology: Hyperandrogenic Disorders (non-PCOS)
  • 9:00 AM - 2:00 PM CT
    PSTR165 - Reproductive Endocrinology: Polycystic Ovary Syndrome III
    Reproductive Endocrinology
  • 9:00 AM - 2:00 PM CT
    PSTR166 - Reproductive Endocrinology: Transgender Medicine and Research in Adults and Adolescents
    Reproductive Endocrinology
  • 9:00 AM - 2:00 PM CT
    PSTR167 - Pediatric and Adolescent Endocrinology: Disorders of Sex Development or Intersex
    Pediatric and Adolescent Endocrinology
  • 9:00 AM - 2:00 PM CT
    PSTR168 - Pediatric and Adolescent Endocrinology: Genetics and Development (including gene regulation)
    Pediatric and Adolescent Endocrinology
  • 9:00 AM - 2:00 PM CT
    PSTR169 - Pediatric and Adolescent Endocrinology: Pediatric Diabetes, Metabolic and Cardiovascular Disorders III
    Pediatric and Adolescent Endocrinology
  • 9:00 AM - 2:00 PM CT
    PSTR170 - Pediatric and Adolescent Endocrinology: Pediatric Growth Disorders III
    Pediatric and Adolescent Endocrinology
  • 9:00 AM - 2:00 PM CT
    PSTR171 - Pediatric and Adolescent Endocrinology: Pediatric Thyroid
    Pediatric and Adolescent Endocrinology
  • 9:00 AM - 2:00 PM CT
    PSTR172 - Pediatric and Adolescent Endocrinology: Pubertal Development and Disorders II
    Pediatric and Adolescent Endocrinology
  • 9:00 AM - 2:00 PM CT
    PSTR173 - Receptor Biology and Signal Transduction III
    Receptor Biology and Signal Transduction
  • 9:00 AM - 2:00 PM CT
    PSTR174 - Cardiovascular Endocrinology: Hormone Systems and Blood Vessel Health (Excluding Primary Aldosteronism) III
    Cardiovascular Endocrinology
  • 9:00 AM - 2:00 PM CT
    PSTR175 - Cardiovascular Endocrinology: Lipids III
    Cardiovascular Endocrinology
  • 9:00 AM - 2:00 PM CT
    PSTR176 - Tumor Biology: Cancer Targets and Therapies III
    Tumor Biology
  • 9:00 AM - 2:00 PM CT
    PSTR177 - Tumor Biology: Endocrine Neoplasia (including MEN, VHL, and carcinoid; excluding thyroid neoplasia) III
    Tumor Biology
  • 9:00 AM - 2:00 PM CT
    PSTR178 - Tumor Biology: Hormone Dependent Tumors II
    Tumor Biology
  • 9:00 AM - 2:00 PM CT
    PSTR179 - Tumor Biology: Tumor Environment, Progression, and Metastasis III
    Tumor Biology
  • 9:00 AM - 2:00 PM CT
    PSTR180 - Tumor Biology: Tumorigenesis, Biomarkers, Diagnostics, and Therapeutic Targets
    Tumor Biology
  • 9:00 AM - 2:00 PM CT
    PSTR181 - Thyroid Biology and Disease: Benign Thyroid Disorders (other) III
    Thyroid Biology and Disease
  • 9:00 AM - 2:00 PM CT
    PSTR182 - Thyroid Biology and Disease: Hyperthyroidism (auto-immune) III
    Thyroid Biology and Disease
  • 9:00 AM - 2:00 PM CT
    PSTR182 - Thyroid Biology and Disease: Hyperthyroidism (auto-immune) III

    ORF Chair-Primary: Wendy Sacks

    ORF Chair-Primary: Debbie Chen – University of Michigan

  • 9:00 AM - 2:00 PM CT
    PSTR183 - Thyroid Biology and Disease: Hypothyroidism (auto-immune) III
    Thyroid Biology and Disease
  • 9:00 AM - 2:00 PM CT
    PSTR184 - Thyroid Biology and Disease: Papillary Thyroid Cancer III
    Thyroid Biology and Disease
  • 9:00 AM - 2:00 PM CT
    PSTR185 - Thyroid Biology and Disease: Thyroid Cancer (other than PTC) III
    Thyroid Biology and Disease
  • 9:00 AM - 2:00 PM CT
    PSTR186 - Thyroid Biology and Disease: Thyroid Eye Disease II
    Thyroid Biology and Disease
  • 9:00 AM - 2:00 PM CT
    PSTR187 - Thyroid Biology and Disease: Thyroid Hormone Action II
    Thyroid Biology and Disease
  • 9:00 AM - 2:00 PM CT
    PSTR188 - Thyroid Biology and Disease: Thyroid Hormone Regulation III
    Thyroid Biology and Disease
  • 9:00 AM - 2:00 PM CT
    PSTR189 - Thyroid Biology and Disease: Thyroid Nodules III
    Thyroid Biology and Disease
  • 9:00 AM - 2:00 PM CT
    PSTR190 - Adrenal (Excluding Mineralocorticoids): Adrenal Adenomas and Hyperplasia III
    Adrenal (Excluding Mineralocorticoids)
  • 9:00 AM - 2:00 PM CT
    PSTR191 - Adrenal (Excluding Mineralocorticoids): Adrenal Insufficiency III
    Adrenal (Excluding Mineralocorticoids)
  • 9:00 AM - 2:00 PM CT
    PSTR192 - Adrenal (Excluding Mineralocorticoids): General Adrenal II
    Adrenal (Excluding Mineralocorticoids)
  • 9:00 AM - 2:00 PM CT
    PSTR193 - Adrenal (Excluding Mineralocorticoids): Glucocorticoid Actions II
    Adrenal (Excluding Mineralocorticoids)
  • 9:00 AM - 2:00 PM CT
    PSTR194 - Adrenal (Excluding Mineralocorticoids): Other Adrenal Tumors III
    Adrenal (Excluding Mineralocorticoids)
  • 9:00 AM - 2:00 PM CT
    PSTR195 - Adrenal (Excluding Mineralocorticoids): Pheochromocytoma: Diagnosis and Treatment III
    Adrenal (Excluding Mineralocorticoids)
  • 9:00 AM - 2:00 PM CT
    PSTR196 - Diabetes and Vascular Disease: Beta Cell Dynamics and Islet Biology II
    Diabetes and Vascular Disease
  • 9:00 AM - 2:00 PM CT
    PSTR196 - Diabetes and Vascular Disease: Pharmacologic management of Type 2 diabetes using Oral Antidiabetic Agents I
  • 9:00 AM - 2:00 PM CT
    PSTR197 - Diabetes and Vascular Disease: Clinical management of T1D III
    Diabetes and Vascular Disease
  • 9:00 AM - 2:00 PM CT
    PSTR198 - Diabetes and Vascular Disease: Diabetes and Pregnancy III
    Diabetes and Vascular Disease
  • 9:00 AM - 2:00 PM CT
    PSTR199 - Diabetes and Vascular Disease: Diabetes Technology III
    Diabetes and Vascular Disease
  • 9:00 AM - 2:00 PM CT
    PSTR200 - Diabetes and Vascular Disease: Genetics (including gene regulation) and Epidemiology III
    Diabetes and Vascular Disease
  • 9:00 AM - 2:00 PM CT
    PSTR201 - Diabetes and Vascular Disease: Glucose Metabolism and Pre Diabetes III
    Diabetes and Vascular Disease
  • 9:00 AM - 2:00 PM CT
    PSTR202 - Diabetes and Vascular Disease: Hypoglycemia III
    Diabetes and Vascular Disease
  • 9:00 AM - 2:00 PM CT
    PSTR203 - Diabetes and Vascular Disease: Immunology and Transplantation III
    Diabetes and Vascular Disease
  • 9:00 AM - 2:00 PM CT
    PSTR204 - Diabetes and Vascular Disease: Insulin Signaling and Action III
    Diabetes and Vascular Disease
  • 9:00 AM - 2:00 PM CT
    PSTR205 - Diabetes and Vascular Disease: Microvascular or Macrovascular Disease in Diabetes III
    Diabetes and Vascular Disease
  • 9:00 AM - 2:00 PM CT
    PSTR206 - Diabetes and Vascular Disease: Non-Vascular Complications of Diabetes in the nervous and musculoskeletal systems III
    Diabetes and Vascular Disease
  • 9:00 AM - 2:00 PM CT
    PSTR207 - Diabetes and Vascular Disease: Pharmacologic Management of Type 2 Diabetes using Injectable Therapies III
    Diabetes and Vascular Disease
  • 9:00 AM - 2:00 PM CT
    PSTR208 - Diabetes and Vascular Disease: Prevention of Type 2 Diabetes and Non pharmacologic management of Type 2 diabetes III
    Diabetes and Vascular Disease
  • 9:00 AM - 2:00 PM CT
    PSTR209 - Adipose Tissue, Appetite, and Obesity: Adipocyte Biology III
    Adipose Tissue_Appetite_and Obesity
  • 9:00 AM - 2:00 PM CT
    PSTR210 - Adipose Tissue, Appetite, and Obesity: Diagnosis of obesity and related complications III
    Adipose Tissue_Appetite_and Obesity
  • 9:00 AM - 2:00 PM CT
    PSTR211 - Adipose Tissue, Appetite, and Obesity: Emerging Pharmacotherapies Targeting Obesity and Cardiometabolic Diseases: Mechanisms and Efficacy III
    Adipose Tissue_Appetite_and Obesity
  • 9:00 AM - 2:00 PM CT
    PSTR212 - Adipose Tissue, Appetite, and Obesity: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) III
    Adipose Tissue_Appetite_and Obesity
  • 9:00 AM - 2:00 PM CT
    PSTR213 - Adipose Tissue, Appetite, and Obesity: Monogenic and Syndromic Obesity II
    Adipose Tissue_Appetite_and Obesity
  • 9:00 AM - 2:00 PM CT
    PSTR214 - Adipose Tissue, Appetite, and Obesity: Therapeutics of Obesity III
    Adipose Tissue_Appetite_and Obesity
  • 9:00 AM - 2:00 PM CT
    PSTR215 - Bone and Mineral Metabolism: Genetic and Rare Bone/Mineral Metabolism Disorders III
    Bone and Mineral Metabolism
  • 9:00 AM - 2:00 PM CT
    PSTR216 - Bone and Mineral Metabolism: Hypocalcemia and Hypoparathyroidism III
    Bone and Mineral Metabolism
  • 9:00 AM - 2:00 PM CT
    PSTR217 - Bone and Mineral Metabolism: Non-PTH Hypercalcemia III
    Bone and Mineral Metabolism
  • 9:00 AM - 2:00 PM CT
    PSTR218 - Bone and Mineral Metabolism: Osteoporosis in Special Populations III
    Bone and Mineral Metabolism
  • 9:00 AM - 2:00 PM CT
    PSTR219 - Bone and Mineral Metabolism: Other Bone Conditions II
    Bone and Mineral Metabolism
  • 9:00 AM - 2:00 PM CT
    PSTR220 - Bone and Mineral Metabolism: Phosphate Disorders II
    Bone and Mineral Metabolism
  • 9:00 AM - 2:00 PM CT
    PSTR221 - Bone and Mineral Metabolism: Postmenopausal Osteoporosis III
    Bone and Mineral Metabolism
  • 9:00 AM - 2:00 PM CT
    PSTR222 - Bone and Mineral Metabolism: Preclinical Calcium, Parathyroid Hormone and Vitamin D
    Bone and Mineral Metabolism
  • 9:00 AM - 2:00 PM CT
    PSTR223 - Bone and Mineral Metabolism: Primary Hyperparathyroidism III
    Bone and Mineral Metabolism
  • 9:00 AM - 2:00 PM CT
    PSTR224 - General Endocrinology: Healthcare Delivery and Health Services Research III
    General Endocrinology
  • 9:00 AM - 2:00 PM CT
    PSTR225 - Diabetes and Vascular Disease: Pharmacologic Management of Type 2 Diabetes using Injectable Therapies III

    ORF Chair-Primary: Farah A. Hasan, MD – University of Chicago

  • 9:00 AM - 2:00 PM CT
    PSTR225 - General Endocrinology: Healthcare Education in Endocrinology I
  • 9:00 AM - 2:00 PM CT
    PSTR225 - General Endocrinology: Healthcare Education in Endocrinology III
    General Endocrinology
  • 9:00 AM - 4:00 PM CT
    PSTR161 - Neuroendocrinology and Pituitary: Non-functioning Pituitary Tumors and other Sellar/Parasellar Tumors I
  • 9:30 AM - 10:10 AM CT
    MTP25 - Pituitary Tumor Survivorship: Transitioning from Pediatric to Adult Endocrine Care
    Pediatric and Adolescent Endocrinology
  • 9:30 AM - 10:10 AM CT
    MTP26 - Metabolic Implications of Adrenal Incidentalomas: When Do We Intervene?
    Adrenal (Excluding Mineralocorticoids)
  • 9:30 AM - 10:10 AM CT
    MTP27 - Post-GLP-1: Preparing Patients for Long-Term Maintenance and Transition
    Adipose Tissue_Appetite_and Obesity
  • 9:30 AM - 10:15 AM CT
    PD09 - AI in Medical Education: Opportunities, challenges, and the road ahead
    Moderator: Julie Chen (she/her/hers) – STANFORD University MEDICAL Center
    Panelist: Julie Chen (she/her/hers) – STANFORD University MEDICAL Center
    Panelist: Andrew Crawford – Dartmouth-Hitchcock Clinic
    Panelist: Ruchi Gaba, MD – Baylor College of Medicine
    Panelist: Alastair Thomson, MD – EASTERN VIRGINIA MEDICAL SCHOOL
    General Endocrinology
  • 9:30 AM - 10:15 AM CT
    PL06 - Post-Plenary Discussion: Molecular Mechanisms in Hormone Signaling: From Bench to Bedside
    Moderator: Raghavendra Mirmira, MD, PhD – The University of Chicago
    Plenary Speaker: Barbara Kahn, MD – Beth Israel Deaconess Medical Center
    Plenary Speaker: Daniel Drucker, MD – Mt Sinai Hospital
    Adipose Tissue_Appetite_and Obesity
     CE: 0.75
  • 9:30 AM - 10:15 AM CT
    ORF38 - Menopause and Hormone Therapy
    ORF Chair-Primary: Rivka Dresner-Pollak, MD – HADASSAH HEBREW University Medical Center
    ORF Chair-Primary: Genevieve S. Neal-Perry, MD PhD (she/her/hers) – The University of North Carolina at Chapel Hill
    Reproductive Endocrinology
  • 9:30 AM - 10:15 AM CT
    ORF39 - Immune Nuclear Receptors in Action: From Single Cells to Lifelong Programming
    ORF Chair-Primary: Inez Rogatsky, PhD (she/her/hers) – Hospital for Special Surgery
    ORF Chair-Primary: Laura Solt, PhD – The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology
    Receptor Biology and Signal Transduction
  • 9:30 AM - 10:15 AM CT
    ORF40 - From Liquid Biopsy to AI to Characterize Thyroid Nodules and RFA to Treat Them
    ORF Chair-Primary: Marika Russell, MD – Massachusetts Eye and Ear
    ORF Chair-Primary: Aysegul Eren, MD – OHIO STATE UNIVERSITY MEDICAL CENTER
    Thyroid Biology and Disease
  • 9:30 AM - 10:15 AM CT
    ORF41 - Thyroid Hormone in Pregnancy and in the Developing Brain
    ORF Chair-Primary: Maria Papaleontiou, MD (she/her/hers) – University of Michigan
    Thyroid Biology and Disease
  • 9:30 AM - 10:15 AM CT
    ORF42 - Diabetes and Vascular Disease: Large Data Sets and Trials
    ORF Chair-Primary: Farah A. Hasan, MD (she/her/hers) – University of Chicago
    Diabetes and Vascular Disease
  • 9:30 AM - 10:15 AM CT
    ORF43 - Bone and Mineral Metabolism: Calcium, Bones, and Things In Between
    ORF Chair-Primary: Matthew Drake, MD, PhD – Hospital for Special Surgery
    Bone and Mineral Metabolism
  • 9:30 AM - 10:15 AM CT
    ORF44 - Hypothalamic and Genetic Disorders of Energy Balance
    ORF Chair-Primary: Sylwia Kaeding, MD
    Adipose Tissue_Appetite_and Obesity
  • 9:30 AM - 10:30 AM CT
    SI01-07 - Hypercortisolism: The Evidence, The Evolution, The Implications
  • 9:30 AM - 10:30 AM CT
    SI02-07 - What Good Looks Like: Optimizing Care for Classic Congenital Adrenal Hyperplasia Across the Lifespan, From Clinical and Patient Perspectives
  • 9:30 AM - 10:30 AM CT
    SI03-07 - Mounjaro® (tirzepatide) Product Theater
  • 10:30 AM - 12:00 PM CT
    PD11 - Alternative Funding Strategies
    Professional Development Speaker: Stanley Andrisse, MBA, PhD (he/him/his) – Howard University College of Medicine
    Professional Development Speaker: Joseph Bass, MD,PhD – Northwestern University
    Professional Development Speaker: Francesca Duncan, PhD – NORTHWESTERN UNIVERSITY
    Professional Development Chair: So-Youn Kim, PhD (she/her/hers) – Rutgers New Jersey Medical School
    General Endocrinology
  • 10:30 AM - 12:00 PM CT
    PD12 - Endocrine Society Guideline Methodology: A Primer for Users and Aspiring Panelists
    Professional Development Chair: Christopher R. McCartney, MD – West Virginia University School of Medicine
    Professional Development Chair: Ranganath Muniyappa, MD, PhD – National Institutes of Health
    Professional Development Speaker: Naykky Maruquel Singh Ospina, MD – University of Florida
    Professional Development Speaker: Spyridoula Maraka, MD – Central Arkansas Veteran Healthcare System
    Professional Development Speaker: Juan P. Brito, MD – Care and AI Laboratory, Knowledge and Evaluation Research Unit, Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Medicine, Mayo Clinic
    General Endocrinology
  • 10:30 AM - 12:00 PM CT
    SY41 - Novel Approaches to Understand Pituitary Development, Function, and Disease
    Symposium Chair: Angela Odle, Ph.D. – University of Arkansas for Medical Sciences
    Neuroendocrinology and Pituitary
     CE: 1.5
  • 10:30 AM - 12:00 PM CT
    SY42 - Central Precocious Puberty: Evolving Concepts in Diagnosis, Treatment, and Surveillance
    Symposium Chair: Yee-Ming Chan, MD, PhD (he/him/his) – Boston Children's Hospital
    Pediatric and Adolescent Endocrinology
     CE: 1.5
  • 10:30 AM - 12:00 PM CT
    SY43 - Steroid Receptor Actions in Immunity
    Symposium Chair: Morag J. Young, PhD (she/her/hers) – Baker Heart and Diabetes Institute
    Symposium Chair: Priya D. Issuree, PhD – University of Iowa, Carver College of Medicine MSEP Program
    Receptor Biology and Signal Transduction
     CE: 1.5
  • 10:30 AM - 12:00 PM CT
    SY44 - From Data to Discovery: Computational Approaches in Hormone-Dependent Cancers
    Symposium Chair: Noelle Gillis, PhD (she/her/hers) – University of Vermont
    Tumor Biology
     CE: 1.5
  • 10:30 AM - 12:00 PM CT
    SY45 - The Multifunctional Potential of Thyromimetics
    Symposium Chair: Paul Yen
    Symposium Chair: Federico Salas-Lucia, PhD (he/him/his) – University of Chicago
    Thyroid Biology and Disease
     CE: 1.5
  • 10:30 AM - 12:00 PM CT
    SY46 - Adrenal Insufficiency: From Molecular Mechanisms to Precision Management and Future Therapies
    Symposium Chair: Aled Rees, MD,PhD (he/him/his) – Cardiff University
    Symposium Chair: Wiebke Arlt, MD DSc FRCP FMedSci – MRC Laboratory of Medical Sciences (LMS)
    Adrenal (Excluding Mineralocorticoids)
     CE: 1.5
  • 10:30 AM - 12:00 PM CT
    SY47 - Hot Topics in Pancreatic Islets: From Basic Mechanisms to Therapeutic Strategies
    Symposium Chair: Dawn B. Davis, MD,PhD (she/her/hers) – University of Wisconsin - Madison
    Diabetes and Vascular Disease
     CE: 1.5
  • 10:30 AM - 12:00 PM CT
    SY48 - MASLD 2026 Updates: From Pathophysiology to Integrated Management and Emerging Therapies
    Symposium Chair: Michael Roden, Dr. – German Diabetes Center
    Symposium Chair: Lisa Chow, MD, MS
    Adipose Tissue_Appetite_and Obesity
     CE: 1.5
  • 10:30 AM - 12:00 PM CT
    SY49 - Bouncing Back From Denosumab Discontinuation
    Symposium Chair: Weiwen Chen
    Symposium Chair: Christian Girgis, MBBS PhD FRACP (he/him/his) – UNIVERSITY OF SYDNEY
    Bone and Mineral Metabolism
     CE: 1.5
  • 11:00 AM - 12:00 PM CT
    SIG06 - Obesity SIG: Obesity Unfiltered: Complicated Cases That Divide the Room
    SIG Chair: Jaime Almandoz, MD, MBA, DABOM, FTOS – UT Southwestern Medical Center
    SIG Speaker: Dimpi Desai, MD – Stanford University
    SIG Speaker: Priya Jaisinghani
    SIG Speaker: Marcelo Correia, MD MSc PhD DABOM – University of Iowa
    SIG Speaker: Jami Josefson, MD, MS – Ann & Robert H Lurie Children's Hospital of Chicago
    Adipose Tissue_Appetite_and Obesity
  • 11:00 AM - 12:30 PM CT
    Past Officers' Luncheon (by invitation only)
  • 12:30 PM - 1:30 PM CT
    SI01-08 - Advancing Acromegaly Management: Bridging Clinical Evidence and the Patient Journey with PALSONIFY™ (paltusotine)
  • 12:30 PM - 1:30 PM CT
    SI02-08 - TSHR Autoantibodies in the Management of Graves' Disease: Present and Future Strategies
  • 12:30 PM - 1:30 PM CT
    SI03-08 - IMCIVREE: Targeted treatment for acquired hypothalamic obesity (HO)
  • 12:45 PM - 1:45 PM CT
    Members' Business Meeting
  • 1:45 PM - 2:25 PM CT
    MTP28 - Diabetic Nephropathy: What Is the Evidence in 2026 for Management of Diabetic Nephropathy?
    Diabetes and Vascular Disease
  • 1:45 PM - 2:25 PM CT
    MTP29 - Osteoporosis in Women with Breast Cancer
    Bone and Mineral Metabolism
  • 1:45 PM - 2:25 PM CT
    MTP30 - Redefining the Role of RAI in Differentiated Thyroid Carcinoma
    Thyroid Biology and Disease
  • 1:45 PM - 3:15 PM CT
    PD13 - Contract Negotiation for Clinicians
    Professional Development Speaker: Milay LUIS LAM, MD – Meritus Medical Center
    Professional Development Speaker: Maria Bernal, MD – Apex Endocrinology Health PLLC
    Professional Development Speaker: Jeffrey Boord, MD,MPH – Parkview Health
    Professional Development Chair: Imali Sirisena
    General Endocrinology
  • 1:45 PM - 3:15 PM CT
    ORF45 - Neuroendocrinology: Plasticity, Reproduction, and Metabolic Control
    Neuroendocrinology and Pituitary
  • 1:45 PM - 3:15 PM CT
    ORF46 - Outcomes of Sex Hormone Therapy
    ORF Chair-Primary: Sandeep S. Dhindsa, MD – Saint Louis University
    Reproductive Endocrinology
  • 1:45 PM - 3:15 PM CT
    ORF47 - Pediatric and Adolescent Endocrinology: Growth and Puberty
    ORF Chair-Primary: Katie O'Sullivan, MD (she/her/hers) – University of Chicago
    Pediatric and Adolescent Endocrinology
  • 1:45 PM - 3:15 PM CT
    ORF48 - Reprogramming Steroid and Nuclear Receptor Networks in Cancer: From Chromatin Crosstalk to Targets
    ORF Chair-Primary: Matthew J. Sikora, PhD (he/him/his) – University of Colorado Anschutz Medical Campus
    Receptor Biology and Signal Transduction
  • 1:45 PM - 3:15 PM CT
    ORF49 - See Through TED
    ORF Chair-Primary: Debbie Chen, MD (she/her/hers) – University of Michigan
    Thyroid Biology and Disease
  • 1:45 PM - 3:15 PM CT
    ORF50 - Adipose Tissue, Appetite, and Obesity: Emerging and Established Pharmacotherapies
    ORF Chair-Primary: Fernando Ovalle, MD – University of Alabama at Birmingham
    ORF Chair-Primary: Elif A. Oral, MD (she/her/hers) – University of Michigan
    Adipose Tissue_Appetite_and Obesity
  • 1:45 PM - 3:15 PM CT
    ORF51 - New Neuroendocrine Pathways Controlling Appetite and Metabolism
    ORF Chair-Primary: Sangeeta Kashyap, MD – Weill Cornell New York Presbyterian Hospital
    Adipose Tissue_Appetite_and Obesity
  • 2:35 PM - 3:15 PM CT
    MTP31 - Use of Adjunctive Therapies to Target Cardiometabolic Risk in Type 1 Diabetes
    Diabetes and Vascular Disease
  • 2:35 PM - 3:15 PM CT
    MTP32 - Beyond Basic DXA
    Bone and Mineral Metabolism
  • 2:35 PM - 3:15 PM CT
    MTP33 - Targeted Therapy in Advanced Thyroid Cancer
    Thyroid Biology and Disease
  • 3:30 PM - 4:10 PM CT
    MTP34 - Updates in the Management of Pituitary Apoplexy
    Neuroendocrinology and Pituitary
  • 3:30 PM - 4:10 PM CT
    MTP35 - Update on Management of Androgen Insensitivity Syndromes
    Reproductive Endocrinology
  • 3:30 PM - 4:10 PM CT
    MTP36 - Interpreting Aldosterone and Renin: Tricks of the Trade
    Cardiovascular Endocrinology
  • 3:30 PM - 4:10 PM CT
    MTP37 - Challenges in the Diagnosis and Management of Adrenal Insufficiency
    Adrenal (Excluding Mineralocorticoids)
  • 3:30 PM - 4:15 PM CT
    MC02 - Overcoming the Adverse Metabolic State in Adolescents with Obesity and Insulin Resistance
    Master Clinician Moderator: Madhusmita Misra, MD, MPH (she/her/hers) – UNIVERSITY OF VIRGINIA
    Pediatric and Adolescent Endocrinology
     CE: 0.75
  • 3:30 PM - 4:15 PM CT
    PD14 - Strategies for a Successful Job Search
    Professional Development Speaker: Komal Kinger, MD – Wellstar Health System
    Professional Development Speaker: Ana Del Carmen Rivadeneira Rodriguez, MD – ALBERT EINSTEIN MEDICAL CENTER
    Professional Development Speaker: Christine Krieger, PhD (she/her/hers) – NIH/NIDDK
    General Endocrinology
  • 3:30 PM - 4:15 PM CT
    YI02 - Year In Bone
    Year In Moderator: Yumie Rhee, MD,PhD – Yonsei University College of Medicine
    Bone and Mineral Metabolism
     CE: 0.75
  • 3:30 PM - 4:15 PM CT
    MTS05 - At the Interface Between Cartilage, Synovial Tissues, and Pain: Using State-of-the-Art Strategies to Dissect Cell-to-Cell Interactions
    Meet the Scientist Chair: Joy Y. Wu, MD, PhD – Stanford University School of Medicine
    General Endocrinology
     CE: 0.75
  • 3:30 PM - 4:15 PM CT
    MTS06 - Best Practices and Considerations in Metabolic Phenotyping: From Rodents to Humans
    Meet the Scientist Chair: Sean Hartig, PhD – Baylor College of Medicine
    General Endocrinology
     CE: 0.75
  • 4:30 PM - 6:00 PM CT
    MC03 - Devices and Technologies Shaping Diabetes Care in 2026
    Master Clinician Moderator: Marina Basina, MD – Stanford University Medical Center
    Diabetes and Vascular Disease
     CE: 1.5
  • 4:30 PM - 6:00 PM CT
    PD15 - Choose Your Own Adventure: Non-Clinical Career Paths in Endocrinology
    Professional Development Chair: Elizabeth Murphy, MD,DPhil – UCSF- SF General Hospital
    Professional Development Speaker: Anne Cappola, MD, ScM – Perelman SOM, University of Pennsylvania
    Professional Development Speaker: Puneet S. Arora, MBBS,MS,FACE – AbbVie
    Professional Development Speaker: Sophia Kaska, Ph.D. (she/her/hers) – Endocrine Society
    Professional Development Speaker: Leonid Katz
    Professional Development Speaker: Matthew Schiewer, PhD – Myriad Genetics
    General Endocrinology
  • 4:30 PM - 6:00 PM CT
    SY50 - Bringing the Background to the Foreground: Advances in Understanding the Posterior Pituitary Gland
    Symposium Chair: Beatriz Soares, PhD,MD – Universidade Federal de Minas Gerais
    Neuroendocrinology and Pituitary
     CE: 1.5
  • 4:30 PM - 6:00 PM CT
    SY51 - Translational and Clinical Insights Into PCOS
    Symposium Chair: Melanie G. Cree, MD, PhD (she/her/hers) – University of Colorado Anschutz
    Reproductive Endocrinology
     CE: 1.5
  • 4:30 PM - 6:00 PM CT
    SY52 - Growth Disorders: Emerging Insights and Innovative Therapeutic Approaches
    Symposium Chair: Alexsandra Malaquias, PhD (she/her/hers) – Faculdade de Ciencias Medicas da Santa Casa de Sao Paulo
    Symposium Chair: Andrew Dauber, MD (he/him/his) – Children's National Hospital
    Pediatric and Adolescent Endocrinology
     CE: 1.5
  • 4:30 PM - 6:00 PM CT
    SY53 - Degrader Revolution: Reimagining Hormone Receptor Targeting
    Symposium Chair: Donald McDonnell, PhD – Duke University School of Medicine
    Symposium Chair: Daniel Frigo, PhD – University of Texas MD Anderson Cancer Center
    Receptor Biology and Signal Transduction
     CE: 1.5
  • 4:30 PM - 6:00 PM CT
    SY54 - Environmental Exposures and Development of Hormone-Dependent Cancers
    Symposium Chair: Lindsey Trevino, PhD – City of Hope National Medical Center
    Tumor Biology
     CE: 1.5
  • 4:30 PM - 6:00 PM CT
    SY55 - Key Evaluation of Thyroid Nodules
    Symposium Chair: Sara Ahmadi, MD – BRIGHAM AND WOMEN'S HOSPITAL
    Thyroid Biology and Disease
     CE: 1.5
  • 4:30 PM - 6:00 PM CT
    SY56 - From Bench to Bedside: Tools for Personalized Care in Adrenal Disorders
    Symposium Chair: Irina Bancos, MD (she/her/hers) – Mayo Clinic Rochester
    Symposium Chair: Livia Mermejo, MD, PhD (she/her/hers) – Ribeirao Preto Medical School, University of Sao Paulo
    Adrenal (Excluding Mineralocorticoids)
     CE: 1.5
  • 4:30 PM - 6:00 PM CT
    SY57 - Hot Topics in Obesity Care in the GLP-1 Era: Biology, Safety, and Value in Chronic Disease
    Symposium Chair: Preeti Kishore, MD – Jacobi Medical Center
    Symposium Chair: Maria Escobar Vasco, MD – UT Health San Antonio
    Adipose Tissue_Appetite_and Obesity
     CE: 1.5
  • 4:30 PM - 6:00 PM CT
    SY58 - From Hormones to Hardware: Endocrinology’s Role in Orthopedics
    Symposium Chair: Robert Weber, MD, PhD (he/him/his) – UCSF
    Symposium Chair: Susan Bukata
    Bone and Mineral Metabolism
     CE: 1.5
  • 6:00 PM - 7:30 PM CT
    Basic Science Reception
  • 7:00 PM - 9:00 PM CT
    From Crisis to Control: Strategies to Address Recurrent Severe Hypoglycemia in Type 1 Diabetes